Prognostic value of myeloperoxidase in patients with chest pain.
about
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromesCan tissue-based immune markers be used for studying the natural history of cancer?The molecular mechanisms of the thrombotic complications of atherosclerosisPentoxifylline for vascular health: a brief review of the literatureAntioxidant therapy for treatment of inflammatory bowel disease: Does it work?Protein carbamylation and cardiovascular diseaseAdvances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicineCardiac biomarkers: new tools for heart failure managementTyrosine modifications in agingBasic MR relaxation mechanisms and contrast agent design3-nitrotyrosine modified proteins in atherosclerosisMyeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechinInteractions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart StudyEffect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factorsHDL-apoA-I exchange: rapid detection and association with atherosclerosisThe roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.The vascular effects of infection in Pediatric Stroke (VIPS) Study.Targeted subendothelial matrix oxidation by myeloperoxidase triggers myosin II-dependent de-adhesion and alters signaling in endothelial cells.A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo.Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cellsQuick identification of acute chest pain patients study (QICS).Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyMagnetic nanoparticle biosensors.Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity.Dysfunctional HDL as a diagnostic and therapeutic targetDesign and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbiditySite-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasoundHigher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adultsConcurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.Bioluminescence imaging of myeloperoxidase activity in vivo.Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjectsThe knowledge-integrated network biomarkers discovery for major adverse cardiac eventsOptimization based tumor classification from microarray gene expression data.Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcificationTargeted probes for cardiovascular MRIMass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.
P2860
Q21342799-FDE22B6E-7A96-4DE1-9517-5F18F991A1AFQ24605537-A1128D7D-EBE3-4B98-8FE2-C5192B614768Q24656816-6B06ED8E-6BB6-4CFF-B97A-2AC2312E88BDQ26766371-D833449E-D296-4599-9EA7-738EBFB98866Q26777641-3EE03D18-45E8-4A18-824D-B36A8B114D34Q26827410-625FB8DF-F982-4226-9DE4-4E628C09CB3EQ26863117-1A327A8A-C5BC-4D44-865D-B623170F5FA8Q26991726-769529C5-C57B-4694-8DD9-534B0BB34F97Q26998450-86347646-1B57-4A47-A1F3-1BAD6714305EQ27692546-7320963B-2297-4E7B-BFFD-8C1A1A88CCF6Q28083260-5F30F063-85D2-41E2-A103-9BCE4045120DQ28200597-80076562-FD38-41DC-978B-F2CEB162FD7CQ28244928-8114FBDA-B38D-4370-8CFA-B53E56CD6404Q28287127-71100002-881C-472E-B95E-D1E89779B086Q28535779-FB7BAE9E-1E6F-4D84-A227-F93B9A896EFCQ30240734-B59167BE-4FEB-44FB-B74A-AF7C4EE807A4Q30425204-CCEF5DC6-56DF-449A-B800-B9B2B11F0F7DQ30530606-B63654BB-E753-4D51-BD82-413654A7BB71Q30562239-836B3CB5-CF2D-433E-9B4A-801EB1A88BBDQ31060150-38BBDC4E-A0D5-48A0-99D3-8224981007BEQ33467558-C7FDC103-6318-47FC-80AC-4D57A4310A05Q33530066-99C54816-508C-42DC-9A84-AF7318AD8968Q33545705-2BE9F885-D54A-4C4C-AE19-CE17B9E69652Q33575669-EB637C2F-1692-4AC5-8DF0-22C7FFCAD1CDQ33604003-628D399E-7DA9-4730-B978-07224966C26CQ33621941-BACD9BA3-2442-4859-9A20-A0E551637737Q33675617-5CC4C2CD-36BE-4DD2-9CE0-5C3F41765446Q33688005-3459827D-DB0C-4127-904E-2AA97E1ADE57Q33691689-453C6C72-8B5E-46E7-9ACB-303FCE942AD9Q33691730-E5A27479-94FC-474C-8D6C-212C3DE45ED2Q33700977-E64A9D12-4209-4F9D-9954-F1609DFA7782Q33706806-69B5D9D5-BBC7-4F56-BB83-3B0D500BFDBDQ33709886-E3DEAFC2-7595-4783-9418-83D909E62556Q33722676-3CED7AB0-B622-4C7F-AA60-063225AE8CE4Q33723943-33E1E692-2220-4E20-99D5-F05400F33114Q33789038-B639B015-7058-4100-B313-3FD305C93149Q33822080-68F199C3-3B13-4036-80E7-70A9FABB9431Q33858743-D2E47584-C8FA-4A4E-B235-580B16F71B84Q33901726-A9FD5D42-5012-4FB7-9E38-1865B1FE7BDAQ33922502-ACCB4F30-2637-4763-8549-1552D8246025
P2860
Prognostic value of myeloperoxidase in patients with chest pain.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prognostic value of myeloperoxidase in patients with chest pain.
@ast
Prognostic value of myeloperoxidase in patients with chest pain.
@en
Prognostic value of myeloperoxidase in patients with chest pain.
@nl
type
label
Prognostic value of myeloperoxidase in patients with chest pain.
@ast
Prognostic value of myeloperoxidase in patients with chest pain.
@en
Prognostic value of myeloperoxidase in patients with chest pain.
@nl
prefLabel
Prognostic value of myeloperoxidase in patients with chest pain.
@ast
Prognostic value of myeloperoxidase in patients with chest pain.
@en
Prognostic value of myeloperoxidase in patients with chest pain.
@nl
P2093
P356
P1476
Prognostic value of myeloperoxidase in patients with chest pain.
@en
P2093
Ellen S McErlean
Frederick Van Lente
Marc S Penn
Marie-Luise Brennan
Marlene Goormastic
Mehdi H Shishehbor
Michael L Pepoy
Ronnier J Aviles
Stanley L Hazen
Steven E Nissen
P304
P356
10.1056/NEJMOA035003
P407
P50
P577
2003-10-01T00:00:00Z